Draco Healthcare Consulting, LLC is a leader in healthcare consulting focusing the Greater China region and is committed to providing consulting service of highest-quality to leading pharmaceutical and biotech companies worldwide. Draco focuses exclusively on China's healthcare market, including pharmaceutical industry analysis, Chinese drug regulatory environment, China's unique hospital systems and China's complicated epidemiology data. Draco has a dedicated professional team composed of experienced healthcare consultants from pharmaceuticals and biotech industry veterans. Draco’s proprietary databases, tools, and multi-client reports include:
• China CancerMPact® Treatment Architecture Report (co-developed with Kantar Health)
• China Epidemiology Report (cancers and non-cancer diseases)
• China Hospital Prescription Drug (CPD) Sales Reports
For more information please visit www.dracohealthcare.com.